Evidence map›Paper›PMID 39637742›Full record

ArticleBiosensors & bioelectronics2025

Compact multiplex PCR device for HIV-1 and HIV-2 viral load determination from finger-prick whole blood in resource-limited settings.

Tianyi Liu, Anthony J Politza, Md Ahasan Ahamed, Aneesh Kshirsagar, Yusheng Zhu, Weihua Guan

Abstract read
In one paragraph

Article in Biosensors & bioelectronics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tianyi LiuDepartment of Electrical Engineering, Pennsylvania State University, University Park, 16802, USA.
Anthony J PolitzaDepartment of Biomedical Engineering, Pennsylvania State University, University Park, 16802, USA.
Md Ahasan AhamedDepartment of Electrical Engineering, Pennsylvania State University, University Park, 16802, USA.
Aneesh KshirsagarDepartment of Electrical Engineering, Pennsylvania State University, University Park, 16802, USA.
Yusheng ZhuDepartment of Pathology and Laboratory Medicine, Pennsylvania State University, Hershey, 17033, USA.
Weihua GuanDepartment of Electrical Engineering, Pennsylvania State University, University Park, 16802, USA; Department of Biomedical Engineering, Pennsylvania State University, University Park, 16802, USA. Electronic address: wzg111@psu.edu.

Funding

Severity Predictors Integrating salivary Transcriptomics and proteomics with Multi neural network Intelligence in SARS-CoV2 infection in Children (SPITS MISC)R33HD105610 · NICHD · CENTRAL MICHIGAN UNIVERSITY · PI HICKS, STEVEN DANIEL, SETHURAMAN, USHA · 2023 to 2023
$1.4M
Home Fingerprick Blood-Based HIV Self-Test For Quantitative Monitoring Of Viral ReboundR33AI147419 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI GUAN, WEIHUA · 2023 to 2024
$1.3M
Home Fingerprick Blood-Based HIV Self-Test For Quantitative Monitoring Of Viral ReboundR61AI147419 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI GUAN, WEIHUA · 2020 to 2022
$1.0M
NIAID NIH HHS R33 AI147419NIAID NIH HHS R61 AI147419NICHD NIH HHS R33 HD105610
6 · The paper itself

Abstract

The human immunodeficiency virus (HIV) remains a major global health concern for which accurate viral load monitoring is essential for the management of HIV infection. The advent of antiretroviral therapy (ART) has transformed once-fatal HIV disease into a manageable chronic condition that now makes the need for VL testing which aims to satisfy international suppression targets 95-95-95 al l the more essential. Therefore, considering the complexity and diversity of HIV infection, it is essential to develop rapid diagnostic technologies suitable for different clinical situations. Here, we report on a multiplexed PCR device developed for simple and efficient quantification of HIV-1 or HIV-2 viral loads using finger-pricked whole blood from rural decentralized settings. This device is comprised of a previously developed RNA extraction module combined with an optimized real-time PCR amplification system. Together, these combine to simultaneously detect and differentiate HIV-1 & 2; as well are adopting a testing control of RNase P allowing for full diagnostic analysis from one sample. Our device also includes an intuitive user interface and is completely autonomous so it can serve individuals in remote areas who are unfamiliar with the field of medical testing. They get the results in a very short time of around 70 min and hence save on testing times without leaving accuracy behind. The efficiency and effectiveness of the device were validated through the analysis of 30 clinical samples, yielding a sensitivity of 100% for both HIV-1 and HIV-2. The specificity was found to be 100% for HIV-1 and 90.91% for HIV-2, demonstrating high diagnostic accuracy. One of the most attractive things about this device is that it comes in comparison to all other counterparts. Given that you can run the assay for less than $10, it could be an economically viable way to use this as a broadscale test in regions where healthcare budgets don't allow others. Hence it is quite a useful device to aid HIV management in resource-limited settings, where conventional laboratory facilities are out of reach due its simplicity and affordability with rapid output. The point-of-care test is an effective, low-cost, high quality diagnostic tool-promoting rapid testing for HIV-inexpensively overcoming the barriers to efficient control of and care in resource-limited settings.

Indexed as

Biosensing TechniquesHIV-1HIV-2HIV InfectionsViral LoadEquipment DesignHumansMultiplex Polymerase Chain ReactionResource-Limited SettingsRNA, ViralRNA, ViralHuman immunodeficiency virusesNucleic acid testingQuantificationReverse transcription polymerase chain reactionSelf-testingViral load

Identifiers

PMID39637742
PMCPMC11701890

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.